tiprankstipranks
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
India Market
ORCHPHARMA
Orchid Pharma Limited
RESEARCH TOOLSreports

Orchid Pharma Limited (ORCHPHARMA) Ratios

0 Followers

Orchid Pharma Limited Ratios

IN:ORCHPHARMA's free cash flow for Q2 2026 was ₹0.32. For the 2026 fiscal year, IN:ORCHPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 3.35 2.83 3.04 1.35 1.65
Quick Ratio
 1.90 1.68 2.03 0.73 0.93
Cash Ratio
 0.20 0.07 0.01 0.06 0.02
Solvency Ratio
 0.12 0.32 0.33 0.19 0.18
Operating Cash Flow Ratio
 0.05 0.07 0.48 0.05 0.38
Short-Term Operating Cash Flow Coverage
 0.24 0.45 8.97 0.10 1.55
Net Current Asset Value
₹ 2.56B₹ 3.87B₹ 4.06B₹ -355.48M₹ -655.33M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.10 0.09 0.27 0.24
Debt-to-Equity Ratio
 0.22 0.14 0.12 0.48 0.41
Debt-to-Capital Ratio
 0.18 0.12 0.10 0.32 0.29
Long-Term Debt-to-Capital Ratio
 0.16 0.09 0.09 0.18 0.24
Financial Leverage Ratio
 1.35 1.33 1.33 1.78 1.72
Debt Service Coverage Ratio
 1.05 2.53 4.71 0.65 0.63
Interest Coverage Ratio
 3.21 5.58 4.64 0.90 -1.01
Debt to Market Cap
 0.11 0.04 0.03 0.21 0.23
Interest Debt Per Share
 58.37 37.30 31.41 89.24 73.85
Net Debt to EBITDA
 3.58 1.06 0.93 2.16 4.24
Profitability Margins
Gross Profit Margin
36.82%38.48%16.62%10.62%41.54%
EBIT Margin
3.87%11.94%13.22%13.14%-4.45%
EBITDA Margin
8.24%15.69%17.33%21.47%11.10%
Operating Profit Margin
5.57%8.80%9.49%4.46%-6.06%
Pretax Profit Margin
2.67%10.79%10.87%8.30%-10.17%
Net Profit Margin
2.33%10.81%11.25%6.96%-0.35%
Continuous Operations Profit Margin
2.33%10.81%11.25%7.97%-10.80%
Net Income Per EBT
87.01%100.19%103.50%83.84%3.43%
EBT Per EBIT
47.95%122.62%114.60%186.21%167.89%
Return on Assets (ROA)
1.10%5.90%5.93%3.78%-0.18%
Return on Equity (ROE)
1.50%7.86%7.88%6.73%-0.30%
Return on Capital Employed (ROCE)
2.99%5.78%6.01%3.48%-3.90%
Return on Invested Capital (ROIC)
2.52%5.61%5.94%2.75%-3.65%
Return on Tangible Assets
1.11%5.96%5.99%3.78%-0.18%
Earnings Yield
0.71%2.51%1.72%2.96%-0.17%
Efficiency Ratios
Receivables Turnover
 4.01 3.81 4.09 3.09 3.28
Payables Turnover
 3.44 2.55 2.97 3.41 1.95
Inventory Turnover
 1.67 1.74 2.58 2.60 1.89
Fixed Asset Turnover
 1.10 1.32 1.27 1.08 0.93
Asset Turnover
 0.47 0.55 0.53 0.54 0.50
Working Capital Turnover Ratio
 3.28 1.75 2.48 4.66 1.98
Cash Conversion Cycle
 202.97 162.85 107.80 151.38 116.81
Days of Sales Outstanding
 90.97 95.74 89.28 118.04 111.26
Days of Inventory Outstanding
 218.07 210.04 141.22 140.27 192.67
Days of Payables Outstanding
 106.07 142.93 122.70 106.93 187.12
Operating Cycle
 309.04 305.78 230.51 258.31 303.93
Cash Flow Ratios
Operating Cash Flow Per Share
 2.27 3.79 26.05 4.49 22.66
Free Cash Flow Per Share
 -29.07 -25.81 12.65 -16.31 19.13
CapEx Per Share
 31.34 29.60 13.40 20.80 3.53
Free Cash Flow to Operating Cash Flow
 -12.79 -6.81 0.49 -3.63 0.84
Dividend Paid and CapEx Coverage Ratio
 0.07 0.13 1.94 0.22 6.42
Capital Expenditure Coverage Ratio
 0.07 0.13 1.94 0.22 6.42
Operating Cash Flow Coverage Ratio
 0.04 0.11 0.93 0.06 0.35
Operating Cash Flow to Sales Ratio
 0.01 0.02 0.15 0.03 0.17
Free Cash Flow Yield
-5.54%-3.30%1.14%-4.26%6.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 140.63 39.84 58.06 33.77 -596.60
Price-to-Sales (P/S) Ratio
 3.27 4.31 6.53 2.35 2.08
Price-to-Book (P/B) Ratio
 2.08 3.13 4.58 2.27 1.80
Price-to-Free Cash Flow (P/FCF) Ratio
 -18.04 -30.33 87.47 -23.50 14.91
Price-to-Operating Cash Flow Ratio
 230.54 206.64 42.47 85.30 12.59
Price-to-Earnings Growth (PEG) Ratio
 -2.20 12.87 0.85 -0.01 6.07
Price-to-Fair Value
 2.08 3.13 4.58 2.27 1.80
Enterprise Value Multiple
 43.32 28.51 38.63 13.10 22.98
Enterprise Value
 28.96B 41.24B 54.82B 18.73B 14.28B
EV to EBITDA
 43.32 28.51 38.63 13.10 22.98
EV to Sales
 3.57 4.47 6.69 2.81 2.55
EV to Free Cash Flow
 -19.67 -31.51 89.62 -28.13 18.29
EV to Operating Cash Flow
 251.64 214.63 43.51 102.14 15.44
Tangible Book Value Per Share
 248.39 246.52 238.71 168.62 158.53
Shareholders’ Equity Per Share
 251.47 249.88 241.80 168.72 158.61
Tax and Other Ratios
Effective Tax Rate
 0.13 >-0.01 -0.04 0.04 -0.06
Revenue Per Share
 160.14 181.78 169.35 163.14 137.09
Net Income Per Share
 3.72 19.65 19.06 11.35 -0.48
Tax Burden
 0.87 1.00 1.04 0.84 0.03
Interest Burden
 0.69 0.90 0.82 0.63 2.29
Research & Development to Revenue
 0.01 <0.01 <0.01 <0.01 0.01
SG&A to Revenue
 0.06 0.10 0.01 0.01 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.17 0.19 1.37 0.40 -47.39
Currency in INR